Opendata, web and dolomites

MOPEAD SIGNED

Models Of Patient Engagement for Alzheimer’s Disease - Sofia ref.: 115985

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "MOPEAD" data sheet

The following table provides information about the project.

Coordinator
FUNDACIO ACE 

Organization address
address: MARQUES DE SENTMENAT 57
city: BARCELONA
postcode: 8014
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.mopead.eu
 Total cost 4˙581˙967 €
 EC max contribution 2˙043˙000 € (45%)
 Programme 1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2))
 Code Call H2020-JTI-IMI2-2015-05-two-stage
 Funding Scheme IMI2-RIA
 Starting year 2016
 Duration (year-month-day) from 2016-10-01   to  2019-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    FUNDACIO ACE ES (BARCELONA) coordinator 311˙684.00
2    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 468˙701.00
3    GMV SOLUCIONES GLOBALES INTERNET SAU ES (TRES CANTOS MADRID) participant 380˙593.00
4    UNIVERZITETNI KLINICNI CENTER LJUBLJANA SI (LJUBLJANA) participant 168˙306.00
5    KLINIKUM DER UNIVERSITAET ZU KOELN DE (KOELN) participant 144˙106.00
6    ASDM CONSULTING BE (AUDERGHEM) participant 118˙299.00
7    STICHTING VUMC NL (AMSTERDAM) participant 97˙347.00
8    ALZHEIMER EUROPE LU (LUXEMBOURG) participant 91˙275.00
9    MODUS RESEARCH AND INNOVATION LIMITED UK (EDINBURGH) participant 82˙143.00
10    FUNDACIO HOSPITAL UNIVERSITARI VALL D'HEBRON - INSTITUT DE RECERCA ES (BARCELONA) participant 74˙322.00
11    EUROPEAN INSTITUTE OF WOMEN'S HEALTH COMPANY LIMITED BY GUARANTEE IE (DUBLIN) participant 45˙688.00
12    KITE INNOVATION (EUROPE) LIMITED UK (HUDDERSFIELD) participant 34˙538.00
13    SPOMINCICA ALZHEIMER SLOVENIJA SLOVENSKO ZDRUZENJE ZA POMOC PRI DEMENCI SI (LJUBLJANA) participant 25˙991.00
14    ASTRAZENECA AB SE (SODERTAELJE) participant 0.00
15    Eli Lilly and Company Limited UK (Basingstoke) participant 0.00

Map

 Project objective

The MOPEAD consortium has proposed a programme of work carefully aligned to the objectives of IMI2 Call to deliver a step-change in AD-related patient engagement (PE) strategies and a paradigm shift in early stage care. It aims to improve patient engagement in three categories: 1) Pre-clinical AD (the most important for prevention trials; 2) Prodromal AD (i.e. MCI with positive amyloid biomarkers); and 3) Very Mild AD. MOPEAD offers four different and complementary strategies, namely AD Citizen-Science, Open House Initiative (OHI), Primary Care Campaign (PCC), and Type 2 Diabetes (T2DM). It seeks subjects eligible for CT scan in all three mentioned categories. The central concept is to test and evaluate the four Patient Engagement models (Runs) to help identify patients at risk of AD in a five-country, multi-centre setting. It builds upon an already successful model, the Open House Initiative pioneered by the coordinator (FACE). Five countries (ES, DE, NL, SE and SL) have been selected to implement these models based upon relevant expertise; the consortium brings together partners for their potential to become long-term assets to European efforts to tackle AD challenges. The methodology involves enhanced pre-screening protocols to select individuals for conventional screening associated to an RCT. Eligible subjects will be invited to formal evaluation using a protocol consensus with EPFIA. MOPEAD possesses confident baseline metrics from which to measure progress and determine the efficacy of PE strategies compared to primary care. Although baseline data exists for only three of the four proposed models, the new model AD Citizen Science approach will add significantly to the holistic approach of the project. The proposal addresses the specific cross-border challenge of improving health care and reducing the economic burden related to AD by means of identifying those patients at risk of developing AD. This will cover a significant gap in the healthcare system.

 Deliverables

List of deliverables.
End of project EU seminar Other 2020-04-14 09:21:32
Public education / awareness raising strategies Documents, reports 2020-04-14 09:21:26
Recommendations for policy makers and regulators Documents, reports 2020-04-14 09:21:19
MOPEAD Outreach- Report on MOPEAD’s collaboration with other AD related projects and wider European Dementia stakeholders Documents, reports 2020-04-14 09:21:11
Economic evaluation report Documents, reports 2020-04-14 09:21:05
Report on comparison and evaluation of efficacy of PE strategies in different countries Documents, reports 2020-04-14 09:20:59
Anonymous Open Access database: MOPEAD’s raw data and results available for use by research community and relevant stakeholders Documents, reports 2020-04-14 09:20:52
Common protocol of evaluation execution report Documents, reports 2020-04-14 09:20:46
Primary Care campaign final execution report Documents, reports 2020-04-02 09:37:02
Online campaign execution reports Documents, reports 2020-04-02 09:36:54
Gender policy brief Other 2020-04-02 09:37:18
Tertiary Care campaign final execution report Documents, reports 2020-04-02 09:37:10
Open House campaign final execution report Documents, reports 2020-03-17 14:22:59
Citizen Science Web design report Documents, reports 2020-03-17 14:22:59
Primary Care campaign strategy report Documents, reports 2020-03-17 14:22:59
Tertiary Care campaign strategy report Documents, reports 2020-03-17 14:22:59
Online Campaign tactic plan report Documents, reports 2020-03-17 14:22:59
Online campaign strategy report Documents, reports 2020-03-17 14:22:59
Open House campaign strategy report Documents, reports 2020-03-17 14:22:59
Leaflets for participants on cognitive health and lifestyle Other 2020-03-17 14:22:59

Take a look to the deliverables list in detail:  detailed list of MOPEAD deliverables.

 Publications

year authors and title journal last update
List of publications.
2019 Octavio Rodríguez-Gómez, Adrián Rodrigo, Fátima Iradier, Miguel A. Santos-Santos, Hans Hundemer, Andreea Ciudin, Lena Sannemann, Marissa Zwan, Bridget Glaysher, Anders Wimo, Jaka Bonn, Gunilla Johansson, Isabel Rodriguez, Montse Alegret, Dianne Gove, Susana Pinó, Paloma Trigueros, Miia Kivipelto, Brandy Mathews, Antonio Ciudad, Daniel Ferreira, Christophe Bintener, Miren Gurruchaga, Eric West
The MOPEAD project: Advancing patient engagement for the detection of “hidden” undiagnosed cases of Alzheimer\'s disease in the community
published pages: 828-839, ISSN: 1552-5260, DOI: 10.1016/j.jalz.2019.02.003
Alzheimer\'s & Dementia 15/6 2020-03-17

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MOPEAD" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MOPEAD" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.7.)

EBOVAC3 (2018)

Bringing a prophylactic Ebola vaccine to licensure

Read More  

PD-MIND (2019)

Parkinson Disease with Mild cognition Impairment treated with Nicotinic agonist Drug

Read More  

STOPFOP (2019)

Saracatinib Trial tO Prevent FOP

Read More